about
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatationA Review of Nebivolol Pharmacology and Clinical EvidenceNebivolol: third-generation beta-blockadeCharacterization of beta(1)-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardiumComparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in manCancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.Nitric oxide: an emerging role in cardioprotection?Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats.The β-blocker Nebivolol Is a GRK/β-arrestin biased agonistThe favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells.Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma.Nebivolol: impact on cardiac and endothelial function and clinical utility.Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol.The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertensionThe Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]iNebivolol: a third-generation beta-adrenergic blocker.The latest generation of beta-blockers: new pharmacologic properties.Management of global risk across the continuum of hypertensive heart disease.Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive ratsA review of the safety and efficacy of nebivolol in the mildly hypertensive patient.Nebivolol in the treatment of chronic heart failure.Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.Nitric oxide mechanisms of nebivolol.Nebivolol for the treatment of heart failure.The Pharmacology of Autonomic Failure: From Hypotension to Hypertension.GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action.Nebivolol: novel beta-blocker with nitric oxide-induced vasodilation.Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells.Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo.Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study.Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.Nebivolol in obese and non-obese hypertensive patients.Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension.Beneficial effects of nebivolol and hydrochlorothiazide combination in spontaneously hypertensive rats.Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.
P2860
Q24681317-86105254-49FF-4716-8427-A58E3A8AC0DCQ26801287-A281CBBA-EDE3-436E-A7EF-B4BEAB531C62Q28238369-0B7B0F5F-DCD2-42AC-B17C-D6C72C0BFEA9Q28363078-B7FE0A0F-9BEF-470E-8FE0-444014CF5D1BQ28367565-B4EA9343-7B7C-4585-8DDD-0AB3B0EDC208Q30426853-64ADEDD3-BCEC-4013-8CC3-4B97BC3ADA66Q34371121-D18AA4CD-80E8-417E-B974-A7DD9403C5FFQ34506047-0B2103C5-23D9-4FD0-B0E1-C633D0D8685CQ34566577-2A708861-1515-4060-B93E-A90F79E89FCDQ34972784-98505223-6923-40AD-BAD5-257C836C0437Q35001265-0E554F39-109D-45FF-8D08-2F55367A49D4Q35592096-23EBA1B5-5EE4-44A7-9B4A-637E06F4F2D3Q35846698-CC7DCEE8-5EFE-4671-AF66-B14D4D9B2F71Q35922161-9D5F2244-1EA5-4223-81DC-963B5823EB57Q36025103-1879D4F8-503F-4CEB-961C-68C9C26009E2Q36157478-F632CE06-B570-4152-B549-1B7677D2F300Q36528216-9F4315F5-58AC-439D-A240-3A08130A3150Q36554941-36F15098-B9DE-4E66-9E8A-A0E48A3D1D32Q36559125-EA4EA40A-9285-481E-9103-BB352F579D19Q36596813-47D35CAD-777D-4933-8E3B-7DC460547F12Q36596852-9949DC2C-A1C2-4522-8639-013EC41074D1Q37031362-33754135-9A25-4D39-9473-BBCA1822F5ACQ37033656-E7A74024-953D-423D-A1B8-CB00FA247D49Q37483065-E84B9542-FCD8-47E7-AFCE-D9F843DC5B50Q37943377-B98334DB-9F9F-4838-AD81-220E5574AA2BQ39052115-FC637C5D-945E-42F0-B493-8B9904CCE15FQ39080324-252FC326-0B99-4108-9771-8D2568E18B67Q40128025-D2ED277C-BA5B-4766-8797-66881036A91CQ40361598-E72A2075-5611-4EA3-BCCA-CED8A1BF0954Q41896349-531EB41C-2ACC-4004-80FA-69F2A0A411B0Q42056599-030C3798-5295-4A27-BBB6-E84C2A60D67DQ42499365-C8688FAF-7AD1-41AD-9B7B-CF52C1DE1926Q42782048-5817046C-E8E8-4643-9D79-8C90D7635921Q43117429-6A43DE16-3C69-424C-B70B-47E08D555AA0Q43690830-1421140D-3CA8-4B4F-98DD-38AA5DCDF7ADQ44648434-ED51A9D4-B8A8-4136-A0C9-3CF62188DD75Q45968754-CBEE01AA-5FC0-4C42-A35B-A41D461F4C96Q46031238-EC303E73-CF9C-4019-AF77-F0DEA56E0230Q46601485-C7556C4A-45B4-4FF4-8F38-88817C950F05Q46722950-4B3870A2-202E-44C5-8DF5-46DE0F310649
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Nitric oxide mediated venodilator effects of nebivolol.
@ast
Nitric oxide mediated venodilator effects of nebivolol.
@en
Nitric oxide mediated venodilator effects of nebivolol.
@nl
type
label
Nitric oxide mediated venodilator effects of nebivolol.
@ast
Nitric oxide mediated venodilator effects of nebivolol.
@en
Nitric oxide mediated venodilator effects of nebivolol.
@nl
prefLabel
Nitric oxide mediated venodilator effects of nebivolol.
@ast
Nitric oxide mediated venodilator effects of nebivolol.
@en
Nitric oxide mediated venodilator effects of nebivolol.
@nl
P2093
P2860
P1476
Nitric oxide mediated venodilator effects of nebivolol.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1994.TB04342.X
P407
P577
1994-09-01T00:00:00Z